CellWell record HH-396133
Increased alpha-fetoprotein receptor in the serum of patients with early-stage breast cancer
R. Moro; J. Gulyaeva -- Tcherkassova; P. Stieber
Current Oncology ยท 2012
In plain language
A serum assay for the alpha-fetoprotein receptor distinguished early-stage breast cancer from normal samples with about 93% to 97% sensitivity and 95% to 100% specificity, outperforming CEA and CA 15-3 in the first sample set.
- Evidence
- Emerging
- Design
- Primary research (design unspecified)
Cite this record: https://thecellwell.org/studies/HH-396133
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.